Disease resistance Dotaz Zobrazit nápovědu
Advances in experimental medicine and biology ; vol. 135
220 s. : il.
American journal of medicine, ISSN 0002-9343 vol. 119, suppl. 6A, June 2006
74 s. : il., tab. ; 28 cm
American journal of medicine. Supplement, ISSN 1548-2766 vol. 117, suppl. 3A, August 2004
57 s. : il., tab. ; 28 cm
sv.
- MeSH
- antibiotická rezistence MeSH
- Publikační typ
- periodika MeSH
- Konspekt
- Farmacie. Farmakologie
- NLK Obory
- farmacie a farmakologie
- mikrobiologie, lékařská mikrobiologie
sv. : tab., grafy ; 24 cm
- MeSH
- bakteriální léková rezistence MeSH
- bakteriologické techniky MeSH
- multirezistentní tuberkulóza epidemiologie MeSH
- sběr dat metody MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- pneumologie a ftizeologie
- farmakoterapie
- bakteriologie
- NLK Publikační typ
- publikace WHO
- studie
American journal of respiratory and critical care medicine. 2, ISSN 1073-449X Supplement Vol. 154
S77 s. : il. ; 30 cm
Journal of acquired immune deficiency syndromes, ISSN 1077-9450 Supplement Vol. 12. 1
22 s. : il. ; 30 cm
Drugs. 1, ISSN 0012-6667 Supplement vol. 58
82 s. : il. ; 26 cm
- MeSH
- diabetes mellitus 2. typu MeSH
- inzulinová rezistence MeSH
- metformin MeSH
- obezita prevence a kontrola MeSH
- rizikové faktory MeSH
- Publikační typ
- kongresy MeSH
- Konspekt
- Lékařské vědy. Lékařství
- NLK Obory
- farmacie a farmakologie
- vnitřní lékařství
xxi, 136 stran : ilustrace, grafy
Antimicrobial resistance (AMR) remains a major public health concern in the WHO European Region, with estimates from the European Union/European Economic Area (EU/EEA) alone showing that each year more than 670 000 infections are due to bacteria resistant to antibiotics and approximately 33 000 people die as a direct consequence. This report is the first in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that includes AMR data from invasive isolates in Europe. The report shows that AMR is widespread in the WHO European Region, although the AMR situation varied widely depending on the bacterial species, antimicrobial group and geographical region. A north-to-south and west-to-east gradient was generally observed, with higher AMR percentages in the southern and eastern parts of Europe. Overall in the EU/EEA, AMR percentages for the bacterial species–antimicrobial group combinations under surveillance continue to be high, with carbapenem resistance in Escherichia coli and Klebsiella pneumoniae (K. pneumoniae) and vancomycin resistance in Enterococcus faecium showing a significant increase during 2016–2020. High percentages of resistance to third-generation cephalosporins and carbapenems in K. pneumoniae and high percentages of carbapenem-resistant Acinetobacter species and Pseudomonas aeruginosa in several countries in the European Region are of concern. Effectively tackling AMR in the WHO European Region requires greater efforts and investments.
- MeSH
- antiinfekční látky MeSH
- bakteriální léková rezistence MeSH
- kontrola infekce MeSH
- sběr dat MeSH
- surveillance populace MeSH
- Konspekt
- Veřejné zdraví a hygiena
- NLK Obory
- veřejné zdravotnictví
- infekční lékařství
- NLK Publikační typ
- publikace WHO